RegenMed Development Organization (ReMDO)
RegenMed Development Organization (ReMDO) is a 501(c)3 non-profit organization dedicated to accelerating the discovery and translation of regenerative medicine therapies. By conducting research to de-risk technologies and promoting biomanufacturing scale-up and automation, ReMDO aims to make regenerative medicine technologies more affordable and expedite their transition to clinical practice. The organization collaborates with thought leaders, research centers, and companies to advance the field and improve patient outcomes.
What We Do
Assists regenerative medicine start-ups and growth companies with new and emerging technologies to support prototyping and initial product development.
Supports innovation from research to commercialization for regenerative medicine start-ups and growth companies by providing space and support, including market potential validation, benefit analysis, financial planning, budgeting, and comprehensive business plans.
Connects an educational ecosystem of colleges, university programs, and technical schools with biomanufacturing staff, engineers, and research leaders to provide training programs.
Develops sets of hydrogels to be used as a tunable bioink compatible with different bioprinting platforms and cell types.
Develops a well-defined, xeno-free basal medium that supports the growth and viability of human cells derived from each of the three germ layers.
Seeks to develop a universal standardized bioreactor platform for the maturation of regenerative medicine clinical products.
Services
Show More (7)Application Area
Funded Projects
Universal Media Supports Cells Derived from 10 Different Tissue Types
ReMDO's initiative aims to reduce FDA regulatory hurdles by creating standardized media and procedures for expanding diverse human cell types across all three germ layers.
Development of a Universal Bioreactor Platform for Regenerative Medicine Clinical Manufacturing
ReMDO is developing a universal, modular bioreactor platform to streamline and scale the production of regenerative medicine therapies.
News & Updates
A guide through the regenerative medicine regulatory landscape.
ReMDO provides grants to support the commercialization of regenerative medicine therapies.
WFIRM's bioprinting research reaches the International Space Station, marking a significant milestone.
The economic impact of the Innovation Quarter, where ReMDO is located, on Forsyth County.
ReMDO was recognized as one of the largest innovation advocacy organizations by the Triad Business Journal.